Romics is a Medical research service provider for bioinformatics analysis.
Provider of medical research service focusing on epigenetic technology. The company has completed more than 2000 epigenetic experiments with a high success rate, providing extremely valuable information for the medical field.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
May 22, 2019 | Seed | ¥10M | 1 | Xiangxiang Capital | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Xiangxiang Capital | Yes | Seed |